319 related articles for article (PubMed ID: 29992293)
1. SRSF9 selectively represses ADAR2-mediated editing of brain-specific sites in primates.
Shanmugam R; Zhang F; Srinivasan H; Charles Richard JL; Liu KI; Zhang X; Woo CWA; Chua ZHM; Buschdorf JP; Meaney MJ; Tan MH
Nucleic Acids Res; 2018 Aug; 46(14):7379-7395. PubMed ID: 29992293
[TBL] [Abstract][Full Text] [Related]
2. Tissue-selective restriction of RNA editing of CaV1.3 by splicing factor SRSF9.
Huang H; Kapeli K; Jin W; Wong YP; Arumugam TV; Koh JH; Srimasorn S; Mallilankaraman K; Chua JJE; Yeo GW; Soong TW
Nucleic Acids Res; 2018 Aug; 46(14):7323-7338. PubMed ID: 29733375
[TBL] [Abstract][Full Text] [Related]
3. Aberrant alternative splicing pattern of ADAR2 downregulates adenosine-to-inosine editing in glioma.
Li Z; Tian Y; Tian N; Zhao X; Du C; Han L; Zhang H
Oncol Rep; 2015 Jun; 33(6):2845-52. PubMed ID: 25873329
[TBL] [Abstract][Full Text] [Related]
4. Accumulation of nuclear ADAR2 regulates adenosine-to-inosine RNA editing during neuronal development.
Behm M; Wahlstedt H; Widmark A; Eriksson M; Öhman M
J Cell Sci; 2017 Feb; 130(4):745-753. PubMed ID: 28082424
[TBL] [Abstract][Full Text] [Related]
5. Adenosine to inosine editing by ADAR2 requires formation of a ternary complex on the GluR-B R/G site.
Jaikaran DC; Collins CH; MacMillan AM
J Biol Chem; 2002 Oct; 277(40):37624-9. PubMed ID: 12163487
[TBL] [Abstract][Full Text] [Related]
6. ADAR2 A-->I editing: site selectivity and editing efficiency are separate events.
Källman AM; Sahlin M; Ohman M
Nucleic Acids Res; 2003 Aug; 31(16):4874-81. PubMed ID: 12907730
[TBL] [Abstract][Full Text] [Related]
7. Structure and sequence determinants required for the RNA editing of ADAR2 substrates.
Dawson TR; Sansam CL; Emeson RB
J Biol Chem; 2004 Feb; 279(6):4941-51. PubMed ID: 14660658
[TBL] [Abstract][Full Text] [Related]
8. A comparative analysis of ADAR mutant mice reveals site-specific regulation of RNA editing.
Costa Cruz PH; Kato Y; Nakahama T; Shibuya T; Kawahara Y
RNA; 2020 Apr; 26(4):454-469. PubMed ID: 31941663
[TBL] [Abstract][Full Text] [Related]
9. Substrate recognition by ADAR1 and ADAR2.
Wong SK; Sato S; Lazinski DW
RNA; 2001 Jun; 7(6):846-58. PubMed ID: 11421361
[TBL] [Abstract][Full Text] [Related]
10. The majority of A-to-I RNA editing is not required for mammalian homeostasis.
Chalk AM; Taylor S; Heraud-Farlow JE; Walkley CR
Genome Biol; 2019 Dec; 20(1):268. PubMed ID: 31815657
[TBL] [Abstract][Full Text] [Related]
11. Base-pairing probability in the microRNA stem region affects the binding and editing specificity of human A-to-I editing enzymes ADAR1-p110 and ADAR2.
Ishiguro S; Galipon J; Ishii R; Suzuki Y; Kondo S; Okada-Hatakeyama M; Tomita M; Ui-Tei K
RNA Biol; 2018; 15(7):976-989. PubMed ID: 29950133
[TBL] [Abstract][Full Text] [Related]
12. RNA-editing enzymes ADAR1 and ADAR2 coordinately regulate the editing and expression of Ctn RNA.
Anantharaman A; Gholamalamdari O; Khan A; Yoon JH; Jantsch MF; Hartner JC; Gorospe M; Prasanth SG; Prasanth KV
FEBS Lett; 2017 Sep; 591(18):2890-2904. PubMed ID: 28833069
[TBL] [Abstract][Full Text] [Related]
13. Altered editing in RNA editing adenosine deaminase ADAR2 gene transcripts of systemic lupus erythematosus T lymphocytes.
Laxminarayana D; O'Rourke KS; Maas S; Olorenshaw I
Immunology; 2007 Jul; 121(3):359-69. PubMed ID: 17376196
[TBL] [Abstract][Full Text] [Related]
14. Dynamic landscape and regulation of RNA editing in mammals.
Tan MH; Li Q; Shanmugam R; Piskol R; Kohler J; Young AN; Liu KI; Zhang R; Ramaswami G; Ariyoshi K; Gupte A; Keegan LP; George CX; Ramu A; Huang N; Pollina EA; Leeman DS; Rustighi A; Goh YPS; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; Chawla A; Del Sal G; Peltz G; Brunet A; Conrad DF; Samuel CE; O'Connell MA; Walkley CR; Nishikura K; Li JB
Nature; 2017 Oct; 550(7675):249-254. PubMed ID: 29022589
[TBL] [Abstract][Full Text] [Related]
15. ADAR2 Is Involved in Self and Nonself Recognition of Borna Disease Virus Genomic RNA in the Nucleus.
Yanai M; Kojima S; Sakai M; Komorizono R; Tomonaga K; Makino A
J Virol; 2020 Feb; 94(6):. PubMed ID: 31852792
[TBL] [Abstract][Full Text] [Related]
16. A novel tissue-specific alternatively spliced form of the A-to-I RNA editing enzyme ADAR2.
Agranat L; Sperling J; Sperling R
RNA Biol; 2010; 7(2):253-62. PubMed ID: 20215858
[TBL] [Abstract][Full Text] [Related]
17. RNA editing by ADAR2 is metabolically regulated in pancreatic islets and beta-cells.
Gan Z; Zhao L; Yang L; Huang P; Zhao F; Li W; Liu Y
J Biol Chem; 2006 Nov; 281(44):33386-94. PubMed ID: 16956888
[TBL] [Abstract][Full Text] [Related]
18. ADAR-related activation of adenosine-to-inosine RNA editing during regeneration.
Witman NM; Behm M; Ohman M; Morrison JI
Stem Cells Dev; 2013 Aug; 22(16):2254-67. PubMed ID: 23534823
[TBL] [Abstract][Full Text] [Related]
19. ADAR-deficiency perturbs the global splicing landscape in mouse tissues.
Kapoor U; Licht K; Amman F; Jakobi T; Martin D; Dieterich C; Jantsch MF
Genome Res; 2020 Aug; 30(8):1107-1118. PubMed ID: 32727871
[TBL] [Abstract][Full Text] [Related]
20. A disrupted RNA editing balance mediated by ADARs (Adenosine DeAminases that act on RNA) in human hepatocellular carcinoma.
Chan TH; Lin CH; Qi L; Fei J; Li Y; Yong KJ; Liu M; Song Y; Chow RK; Ng VH; Yuan YF; Tenen DG; Guan XY; Chen L
Gut; 2014 May; 63(5):832-43. PubMed ID: 23766440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]